C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.950
-0.190 (-6.05%)
At close: Oct 2, 2026, 4:00 PM EDT
3.004
+0.054 (1.82%)
After-hours: Oct 2, 2026, 7:30 PM EDT
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $362.92 million as of October 2, 2026. Its market cap has increased by 137.18% in one year.
Market Cap
362.92M
Enterprise Value
119.33M
1-Year Change
137.18%
Ranking
Category
Stock Price
$2.95
ChartMarket Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $362.92M, a decrease of -53.03%. That is a compound annual growth rate of -11.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 362.92M | 96.06% |
| Dec 31, 2025 | 185.11M | -27.16% |
| Dec 31, 2024 | 254.12M | -8.73% |
| Dec 29, 2023 | 278.44M | -3.60% |
| Dec 30, 2022 | 288.85M | -81.55% |
| Dec 31, 2021 | 1.57B | 9.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 396.73M |
| Turn Therapeutics | 396.48M |
| vTv Therapeutics | 395.73M |
| Relmada Therapeutics | 390.41M |
| Prelude Therapeutics | 390.35M |
| Editas Medicine | 387.02M |
| Orchestra BioMed Holdings | 381.67M |
| Galectin Therapeutics | 379.19M |